ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ABEO vs AMRN // EV/EBITDA & P/E VALUATION

Abeona Therapeutics Inc. (NASDAQ) VS. Amarin Corporation plc (NASDAQ) • 15-METRIC TALLY: ABEO 1 — AMRN 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ABEO VS. AMRN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ABEO AMRN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 73.70% 56.60% +17.10 ABEO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -12.20% -22.80 AMRN /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — 2.56% — TIE /fcf-yield <GO>
Operating Margin -60.00% -23.50% -36.50 AMRN /operating-margins <GO>
Net Profit Margin -60.00% -18.20% -41.80 AMRN /net-margins <GO>
Revenue Growth (YoY) — -6.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 6/9 -3.00 AMRN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 36.1 46.6 -10.58 AMRN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $260.8M $262.8M -$2.0M AMRN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ABEO REV AMRN REV ABEO GROSS % AMRN GROSS % ABEO FCF AMRN FCF
FY 2025 $5.8M $213.6M 73.7% 56.6% -$84.3M $6.7M
FY 2024 $0 $228.6M — 35.6% -$58.5M -$31.0M
FY 2023 $3.5M $306.9M — — -$37.0M $6.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ABEO // BETA —
AMRN // BETA —